Figures computed from official regulatory filings — .
Analysttarget 6.25 USD (+111%) · consensus 4.5/5 · 3 buy · 1 hold · 0 sell
Ownershipinsiders 8.21% · institutions 56.46% · short 2.6% of float
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for KORU Medical Systems, Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the FREEDOM infusion systems to deliver therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 Syringe Driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
198 buys7 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
| CASCELLA ROBERTtrack record | Award | $15K | SEC |
| French Donna | Award | $15K | SEC |
| Matin Shahriartrack record | Award | $15K | SEC |
| Manko Joseph M. Jr.track record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FLETCHER R JOHNtrack record | Award | $22.5K | SEC |
| WHOLIHAN EDWARD | Award | $15K | SEC |
| KALBERMATTEN ADAM R | Buy | $101.1K | conv 52 | SEC |
| KALBERMATTEN ADAM R | Other | $108.6K | SEC |
| KALBERMATTEN ADAM R | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| KALBERMATTEN ADAM R | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| French Donna | Award | $15K | SEC |
| Manko Joseph M. Jr.track record | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| FLETCHER R JOHNtrack record | Award | $22.5K | SEC |
| Matin Shahriartrack record | Award | $15K | SEC |
| WHOLIHAN EDWARD | Award | $15K | SEC |
| CASCELLA ROBERTtrack record | Award | $15K | SEC |
| KALBERMATTEN ADAM R | Buy | $29.5K | conv 68ClusterFirst in 12mo | SEC |
| KALBERMATTEN ADAM R | Buy | $19.8K | conv 68ClusterFirst in 12mo | SEC |
| Tharby Linda Mtrack record | Buy | $1.4M | conv 66ClusterUnusual size+1 | SEC |
| Tharby Linda Mtrack record | Buy | $4.7K | conv 46ClusterFirst in 12mo | SEC |
| Tharby Linda Mtrack record | Exercise | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Tharby Linda Mtrack record | Other | $28.9K | SEC |
| Pazdan Christopher | Buy | $19.4K | conv 54First in 12mo | SEC |
| Pazdan Christopher | Other | $5.8K | SEC |
| Adams Thomas Edward | Buy | $1.8K | conv 61First in 12mo | SEC |